HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 342 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.30 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,618,037 | +2.2% | 42,357 | -3.5% | 0.06% | +8.3% |
| Q2 2023 | $1,583,906 | -8.1% | 43,912 | -2.7% | 0.06% | -11.8% |
| Q1 2023 | $1,723,095 | -26.2% | 45,119 | -0.7% | 0.07% | -27.7% |
| Q4 2022 | $2,336,062 | +28.3% | 45,431 | -1.4% | 0.09% | +14.6% |
| Q3 2022 | $1,821,000 | -11.9% | 46,073 | -1.9% | 0.08% | -7.9% |
| Q2 2022 | $2,066,000 | +7.0% | 46,967 | -3.0% | 0.09% | +29.0% |
| Q1 2022 | $1,930,000 | -0.8% | 48,404 | 0.0% | 0.07% | +4.5% |
| Q4 2021 | $1,946,000 | -1.8% | 48,404 | -0.7% | 0.07% | -8.3% |
| Q3 2021 | $1,982,000 | -7.6% | 48,722 | +3.2% | 0.07% | -6.5% |
| Q2 2021 | $2,145,000 | +12.0% | 47,226 | +2.8% | 0.08% | +5.5% |
| Q1 2021 | $1,915,000 | -3.1% | 45,936 | -0.7% | 0.07% | -19.8% |
| Q4 2020 | $1,976,000 | +550.0% | 46,259 | +299.7% | 0.09% | +550.0% |
| Q3 2020 | $304,000 | -5.6% | 11,573 | -3.5% | 0.01% | -6.7% |
| Q2 2020 | $322,000 | +53.3% | 11,998 | +2.9% | 0.02% | +25.0% |
| Q1 2020 | $210,000 | -2.8% | 11,656 | -4.5% | 0.01% | +20.0% |
| Q4 2019 | $216,000 | +14.3% | 12,201 | 0.0% | 0.01% | +11.1% |
| Q3 2019 | $189,000 | -10.0% | 12,201 | 0.0% | 0.01% | -10.0% |
| Q2 2019 | $210,000 | +22.1% | 12,201 | +14.2% | 0.01% | +25.0% |
| Q1 2019 | $172,000 | +10.3% | 10,685 | 0.0% | 0.01% | -11.1% |
| Q4 2018 | $156,000 | -19.6% | 10,685 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $194,000 | +7.8% | 10,685 | 0.0% | 0.01% | 0.0% |
| Q2 2018 | $180,000 | -9.5% | 10,685 | +5.1% | 0.01% | -10.0% |
| Q1 2018 | $199,000 | -3.4% | 10,168 | 0.0% | 0.01% | +11.1% |
| Q4 2017 | $206,000 | +68.9% | 10,168 | +8.0% | 0.01% | +50.0% |
| Q3 2017 | $122,000 | +0.8% | 9,416 | 0.0% | 0.01% | 0.0% |
| Q2 2017 | $121,000 | -0.8% | 9,416 | 0.0% | 0.01% | 0.0% |
| Q1 2017 | $122,000 | – | 9,416 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |